[Clinical and hematological characteristics of adult T-cell leukemia/lymphoma].
Utsunomya
Atae
A
D001549:Benzamides / Q000627:therapeutic use; D001897:Boronic Acids / Q000627:therapeutic use; D000069286:Bortezomib; D002353:Carrier State / Q000453:epidemiology / Q000635:transmission; D003512:Cyclohexanones / Q000627:therapeutic use; D017320:HIV Protease Inhibitors / Q000627:therapeutic use; D015368:Human T-lymphotropic virus 1; D006801:Humans; D018445:Infectious Disease Transmission, Vertical; D015459:Leukemia-Lymphoma, Adult T-Cell / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy / Q000821:virology; D016328:NF-kappa B / Q000037:antagonists & inhibitors; D011480:Protease Inhibitors / Q000627:therapeutic use; D011719:Pyrazines / Q000627:therapeutic use; D019438:Ritonavir / Q000627:therapeutic use; D033581:Stem Cell Transplantation; D014184:Transplantation, Homologous
D001549:Benzamides; D001897:Boronic Acids; D003512:Cyclohexanones; D017320:HIV Protease Inhibitors; D016328:NF-kappa B; D011480:Protease Inhibitors; D011719:Pyrazines; C464444:dehydroxymethylepoxyquinomicin; D000069286:Bortezomib; D019438:Ritonavir